Related Experiment Videos
Clotiapine for acute psychotic illnesses.
1Cochrane Schizophrenia Group, Summertown Pavilion, Middle Way, Oxford, UK, OX2 7LG. simcarpenter@hotmail.com
The Cochrane Database of Systematic Reviews
|May 2, 2001
Summary
This review found no significant evidence that clotiapine is more effective than other treatments for acute psychotic illness. More high-quality trials are needed to confirm clotiapine
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Acute psychotic illness often requires urgent pharmacological intervention.
- Clotiapine, a dibenzothiazepine neuroleptic, is utilized in several countries for managing agitated or violent behavior in acute psychosis.
Purpose of the Study:
- To assess the efficacy of clotiapine against other treatments for acute psychotic illness.
- The study aimed to evaluate clotiapine's effectiveness in controlling disturbed behavior and reducing psychotic symptoms.
Main Methods:
- A systematic search of multiple databases (Cochrane, EMBASE, MEDLINE, PASCAL, PsycLIT) was conducted.
- Randomized clinical trials comparing clotiapine with other treatments for acute psychotic illnesses were included.
- Data extraction and quality assessment were performed, with specific methods for analyzing binary and continuous outcomes.
Main Results:
- Five trials were included, comparing clotiapine to antipsychotics or benzodiazepines.
- Clotiapine did not demonstrate superiority over chlorpromazine, perphenazine, or trifluoperazine for global clinical outcomes.
- Limited evidence suggested a potential reduction in antiparkinsonian treatment needs with clotiapine compared to zuclopenthixol acetate.
Conclusions:
- No significant evidence supports clotiapine's superiority over other standard or non-standard treatments for acute psychotic illness.
- The included trials had methodological limitations.
- Further high-quality, controlled trials are necessary to establish clotiapine's role in managing acute psychosis.